Home › Hidradenitis Suppurativa › Maryland
Hidradenitis Suppurativa clinical trials in Maryland
3 studies for Hidradenitis Suppurativa are looking for participants at sites in Maryland.
Cities in Maryland
Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
- Investigative Site US038, Baltimore
- Investigative Site US099, Glenn Dale
- Investigative Site US101, Rockville
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT06855498Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa
- Johns Hopkins Univ Schl of Medicine, Baltimore
- Skin Oasis Dermatology, Gambrills
RecruitingPhase 2
Ages 12 to 17 · All sexes · Updated Aug 6, 2026 · NCT07213973Myriad™ Augmented Soft Tissue Reconstruction Registry
- Sinai Hospital of Baltimore, Baltimore
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jul 15, 2026 · NCT05243966From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.